DaVita (NYSE:DVA) Hits New 12-Month High at $149.01

DaVita Inc. (NYSE:DVA) shares reached a new 52-week high during mid-day trading on Wednesday . The stock traded as high as $149.01 and last traded at $148.32, with a volume of 64916 shares changing hands. The stock had previously closed at $145.84.

Analysts Set New Price Targets

Several research analysts have weighed in on the company. TD Cowen increased their price objective on DaVita from $139.00 to $150.00 and gave the stock a “hold” rating in a research report on Wednesday, July 24th. StockNews.com downgraded shares of DaVita from a “strong-buy” rating to a “buy” rating in a report on Saturday, June 8th. UBS Group increased their target price on shares of DaVita from $169.00 to $175.00 and gave the stock a “buy” rating in a research report on Thursday, August 8th. Barclays increased their price target on DaVita from $133.00 to $150.00 and gave the stock an “equal weight” rating in a research report on Monday, May 6th. Finally, Truist Financial lifted their price objective on DaVita from $135.00 to $150.00 and gave the company a “hold” rating in a report on Wednesday, May 15th. One analyst has rated the stock with a sell rating, three have issued a hold rating and two have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, DaVita presently has an average rating of “Hold” and an average target price of $154.00.

DaVita Price Performance

The company has a debt-to-equity ratio of 9.94, a quick ratio of 1.12 and a current ratio of 1.16. The stock has a market capitalization of $12.99 billion, a P/E ratio of 16.91, a PEG ratio of 0.81 and a beta of 0.87. The business has a fifty day simple moving average of $139.98 and a 200-day simple moving average of $134.26.

DaVita (NYSE:DVA) last announced its quarterly earnings results on Tuesday, August 6th. The company reported $2.59 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.47 by $0.12. DaVita had a return on equity of 77.00% and a net margin of 6.86%. The business had revenue of $3.19 billion for the quarter, compared to analyst estimates of $3.15 billion. During the same quarter in the prior year, the company earned $2.08 earnings per share. The company’s quarterly revenue was up 6.2% on a year-over-year basis. Sell-side analysts expect that DaVita Inc. will post 9.9 earnings per share for the current fiscal year.

Institutional Trading of DaVita

Institutional investors and hedge funds have recently modified their holdings of the business. Vanguard Group Inc. increased its stake in shares of DaVita by 2.4% during the 4th quarter. Vanguard Group Inc. now owns 6,320,740 shares of the company’s stock worth $662,161,000 after purchasing an additional 145,711 shares during the last quarter. Gates Capital Management Inc. grew its stake in shares of DaVita by 3.1% during the 4th quarter. Gates Capital Management Inc. now owns 905,830 shares of the company’s stock worth $94,895,000 after acquiring an additional 27,660 shares during the period. 8 Knots Management LLC purchased a new stake in DaVita in the 4th quarter worth about $89,504,000. Allianz Asset Management GmbH raised its stake in DaVita by 63.9% in the 4th quarter. Allianz Asset Management GmbH now owns 548,642 shares of the company’s stock valued at $57,476,000 after acquiring an additional 213,992 shares during the period. Finally, Doma Perpetual Capital Management LLC bought a new position in DaVita during the fourth quarter worth about $53,076,000. 90.12% of the stock is owned by hedge funds and other institutional investors.

About DaVita

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.